Latest Financial Outlook News

Evolution Energy Minerals (EV1) addresses ASX queries over recent share price and volume spikes, attributing the activity to a subsidiary’s new US$2 million term sheet while confirming no undisclosed information.

Maas Group Holdings has reaffirmed its FY25 underlying EBITDA guidance between $215 million and $245 million, while expanding its Melbourne construction materials hub through key acquisitions in asphalt paving and recycling.

Recce Pharmaceuticals has completed a A$15.8 million capital raise to fund pivotal Phase 3 clinical trials and progress its FDA application, positioning the company for potential commercial breakthroughs in antibiotic-resistant infections.

Treasury Wine Estates faces a pivotal shift as RNDC ends its California distribution, prompting a strategic rethink amid a slightly lowered FY25 EBIT forecast.

Judo Capital Holdings Limited reaffirmed its FY25 guidance at its 2025 Investor Day, highlighting strong lending growth, a maturing technology platform, and a focused strategy to optimize its SME banking model.

Perpetual Limited has successfully refinanced its syndicated debt facilities with improved terms, pushing out maturities and lowering its gross debt forecast for FY25.

Manuka Resources has announced a comprehensive 10-year mine plan to produce 13.2 million ounces of silver plus gold credits from its Wonawinta and Mt Boppy projects, leveraging existing infrastructure and an upgraded processing plant.

Develop has initiated significant underground and surface infrastructure works at its Sulphur Springs zinc-copper project in Western Australia, setting the stage for an updated feasibility study and de-risking the project’s development.

Amaero Ltd updates its financial outlook, targeting positive EBITDA by FY2027 and reaffirming a A$72 million capital investment plan despite delays in US Department of Defense contracts.

Propel Funeral Partners has released its FY25 financial guidance projecting steady revenue growth despite temporary industry volume contraction, alongside announcing the upcoming retirement of its Managing Director and Co-Founder.

Brookside Energy has completed the stimulation phase of its Bruins Well in the Anadarko Basin, staying on schedule and budget, with flow-back and first sales planned for the second quarter of 2025.

OncoSil Medical has secured $8.7 million through a placement and share purchase plan to fund commercialization of its pancreatic cancer treatment device, aiming for positive cash flow by mid-2026. Near-completion clinical trials could soon unlock broader market access.